Rescue Pharmacotherapy for OSA

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

July 1, 2023

Primary Completion Date

October 30, 2026

Study Completion Date

October 30, 2026

Conditions
Obstructive Sleep Apnea
Interventions
DRUG

Placebo

Placebo capsule 30 min before bedtime

DRUG

Acetazolamide

The intervention drug will be determined based on altered endotype and administered 30 min before bedtime. Patients will only take one drug of this intervention, which will be subsequently compared to placebo. Patients with increased loop gain will be given Acetazolamide 500 mg.

DRUG

Trazodone

The intervention drug will be determined based on altered endotype and administered 30 min before bedtime. Patients will only take one drug of this intervention, which will be subsequently compared to placebo. Patients with decreased arousal threshold will be given Trazodone 100 mg.

DRUG

Atomoxetine and eszopiclone

The intervention drug will be determined based on altered endotype and administered 30 min before bedtime. Patients will only take one drug of this intervention, which will be subsequently compared to placebo. Patients with decreased muscle responsiveness will be given Atomoxetine and Eszopiclone 80 + 3 mg.

Trial Locations (1)

02115

RECRUITING

Sleep Disorders Research Program Brigham and Women's Hospital, Boston

All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER